The Treatment of Lung Involvement in Systemic Sclerosis

Systemic sclerosis (SSc) patients are often affected by interstitial lung disease (ILD) and, although there have been recent treatment advances, it remains the leading cause of death among SSc, with a 10-year mortality up to 40%. African Americans and subjects with diffuse cutaneous SSc or anti-topo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceuticals (Basel)
Hauptverfasser: Ruaro, Barbara, Confalonieri, Marco, Matucci-Cerinic, Marco, Salton, Francesco, Confalonieri, Paola, Santagiuliana, Mario, Citton, Gloria Maria, Baratella, Elisa, Bruni, Cosimo
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7918752/
https://ncbi.nlm.nih.gov/pubmed/33668530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14020154
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge